Inventors:
David E. Fisher - Newton MA, US
Richard Lin - Boston MA, US
International Classification:
A61K 31/7105, C12Q 1/26, G01N 33/53, A61P 35/00
Abstract:
Methods for treating melanoma and other MITF-related disorders by administering a compound that causes an increase in HIF-1 level or activity (e.g., by increasing the level of HIF-1I in a cell) within cells. Such methods include administration of a compound that is a hydroxylase inhibitor, e.g., a prolyl hydroxylase inhibitor that reduces hydroxylation of HIF-1I thereby causing an increase in HIF-1I in the cell. Such treatment can lead to a decrease in MITF activity or expression.